Kangcheng Kerui Pharmaceutical R&D (Wuhan) Co., Ltd.

Kangcheng Kerui Pharmaceutical R&D (Wuhan) Co., Ltd. is an outsourcing company that integrates pharmaceutical and biotechnology research and development services. The company's main business is to provide chemical drug bioanalysis services for domestic and international pharmaceutical enterprises. The team plans to establish early-stage pharmacokinetic studies of innovative drugs and consistency studies of generic drugs, mainly studying the dynamic changes of drug metabolism in the body, including the processes of drug absorption, distribution, and excretion in the body. It conducts biodistribution and pharmacokinetic studies in humans, analyzing and testing drugs and their metabolites through distribution analysis in blood samples collected from different tissues, organs, and at different time points. It plays a significant role in guiding new drug design, optimizing dosing regimens, improving dosage forms, and providing efficient, fast-acting (or sustained-release), low-toxicity (or low-side-effect) pharmaceutical preparations. In the initial stage, the project will take domestic pharmaceutical enterprises as the entry point, and later gradually expand to undertake overseas orders. While promoting the market, the team will obtain part of its revenue through technical cooperation or technology transfer, and actively explore financing channels to raise funds.